| Today's Open | $5.41 |
|---|---|
| Previous Close | $5.43 |
| Daily Range | $5.22 - $5.43 |
| 52-Week Range | $4.93 - $12.98 |
| Market Cap | $250.8M |
| P/E Ratio | -5.32 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 409,820 |
| Average Daily Volume | 592,344 |
| Current FY EPS | -$1.86 |
Sector
Healthcare
Industry
Drugs
XenoPort, Inc. (XNPT) Description
A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Website: http://www.xenoport.com/
News & Commentary
Does Restless Legs Syndrome Really Shorten Life Span?
A new study suggests a link between this neurological disorder and mortality rates in men.
Taking a page out of the old West, it was a mix of the good, the bad, and the ugly this week in the biotech sector.
XNPT's Top Competitors
(-2.58%)
(-1.74%)
(-1.67%)
(-0.88%)
